Laboratory Products
Enzymatic Creatinine Assay
Dec 19 2008
analysers. It is intended for use for quantitative determination of creatinine in human serum, plasma and urine. The new assay utilises an
enzymatic method to achieve greater accuracy, showing less interference to bilirubin and antibiotics. The new Olympus assay compliments the
current Jaffe method, providing increased accuracy of creatinine measurements for specific patients where potential interferents exists from diabetics, renal failure, liver failure and jaundice specimens.
With a very broad measuring range, the new Olympus enzymatic assay is extremely precise and accurate, demonstrating excellent agreement with the GC/MS reference method. The limit of detection for creatinine using serum settings on an Olympus AU640 analyser was established at 0.88μmol/L.
This assay clearly meets the NKDEP guidelines and will minimise errors in eGFR calculations. The new assay employs the same calibrators and controls as the current Jaffe method, however, to ensure optimal traceability, new set-points for calibrator and target values, as well as ranges for control sera have been assigned. Sold in a kit format, the reagent has improved on board stability of 60 days and a calibration
stability of 14 days for serum and 30 days for urine. Creatinine measurement is the most commonly used indicator of renal function and has proved useful in monitoring patients with renal failure and those undergoing renal dialysis.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark